Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results

Rhea-AI Summary

Boston Scientific (NYSE: BSX) has announced two upcoming events:

1. A conference call on October 23, 2024, at 8:00 a.m. ET to discuss third quarter 2024 financial results and business highlights. The call will be hosted by Mike Mahoney, chairman and CEO, and Dan Brennan, executive VP and CFO. Financial results will be released prior to the call.

2. A virtual investor event on October 30, 2024, from 4:00 – 5:00 p.m. ET following the Transcatheter Cardiovascular Therapeutics (TCT) symposium. This event will feature a cardiology business update and Q&A session with key executives from the company's cardiology division.

Live webcasts and replays for both events will be available on the Boston Scientific investor relations website.

-Company to also host virtual webcast with a cardiology business update-

MARLBOROUGH, Mass., Oct. 2, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2024, on Wednesday, October 23, 2024, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the third quarter on October 23 prior to the conference call.

The company will also host a virtual investor event on Wednesday, October 30, 2024, from 4:00 – 5:00 p.m. ET following Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). Joe Fitzgerald, executive vice president and president of Cardiology, Dr. Ken Stein, executive vice president and global chief medical officer, Lance Bates, executive vice president and president Interventional Cardiology Therapies (ICTx) and Dr. Janar Sathananthan, chief medical officer ICTx, will present a business update and answer questions from investors.

A live webcast and replay for each event will be accessible at htts://investors.bostonscientific.com. The replays will be available approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.  

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-third-quarter-2024-results-302265174.html

SOURCE Boston Scientific Corporation

FAQ

When will Boston Scientific (BSX) release its Q3 2024 financial results?

Boston Scientific will release its Q3 2024 financial results on October 23, 2024, prior to the conference call scheduled for 8:00 a.m. ET on the same day.

Who will host Boston Scientific's (BSX) Q3 2024 earnings call?

The Q3 2024 earnings call will be hosted by Mike Mahoney, chairman and CEO, and Dan Brennan, executive VP and CFO of Boston Scientific.

What is the date and time of Boston Scientific's (BSX) virtual investor event following TCT 2024?

Boston Scientific's virtual investor event following TCT 2024 is scheduled for October 30, 2024, from 4:00 – 5:00 p.m. ET.

Which executives will present at Boston Scientific's (BSX) cardiology business update on October 30, 2024?

The cardiology business update will feature Joe Fitzgerald, Lance Bates, Dr. Ken Stein, and Dr. Janar Sathananthan, who are executives from Boston Scientific's cardiology division.